This has potential for a new approach to chronic pain treatment.” The researchers tested the prodrug’s effectiveness in mouse models of chronic pain that feature localized sites of oxidative stress ...
Clene's cash, cash equivalents and marketable securities totaled $14.6 million as of September 30, 2024, compared to $35.0 million as of December 31, 2023. Clene expects that its resources as of ...